Apple Is No Longer World’s Most Valuable Company

Apple’s stock is down roughly 20% for the year and down nearly 10% so far this month. Photo: SeongJoon Cho/Bloomberg News Updated May 12, 2022 5:24 pm ET Earlier this year, Apple Inc. AAPL 3.19% looked like it was on its way to becoming the first $3 trillion company. Today, it’s no longer the most … Read more

Opinion: 12 stocks to consider for the next leg of the bull market

You may want to wait until the stock market turns up again before expending energy on trying to pick individual companies. That’s because, during bear markets, almost all stocks become correlated with the market. Only once a new bull market starts do correlations fall, and that’s when you have relatively good odds of picking stocks … Read more

Morgan Stanley’s done better than most forecasting markets during this turbulent year. Here’s what it says is coming next.

Wall Street analysts are the types who get to the airport with hours to spare. Year-ahead previews come in before Thanksgiving, so it can’t be too huge a surprise that Morgan Stanley has released its mid-year outlook just 11 days into May. Not that anyone has seen what 2022 had in store — the worst … Read more

These money and investing tips can help you juggle whatever the stock market throws at you

Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING NEWS & TRENDS Welcome to Generation Z’s first bear market Up until recently, young people’s primary experience of the market was that stocks almost always go up Read More The … Read more

The FDA Approved Eli Lilly’s Diabetes Drug. But the Most Exciting Market May Be Something Else.

text size While the S&P 500 has dropped 4.4% in the past 12 months, Eli Lilly shares are up 50%. Jonathan Weiss/Dreamstime The US Food and Drug Administration approved Eli Lilly ‘s novel treatment for diabetes on Friday, in a widely anticipated move after the drug led to impressive drops in blood sugar and body … Read more

Has the junk-bond market hit bottom? Liquidity issues may be up next, warns this industry veteran

Don’t call it a dash-for-trash quite yet. US corporate bonds with riskier high-yield or “junk” credit ratings finally might look like a buy, after a brutal start to 2022 sparked by central bankers looking to end an era of easy-money. Prices for junk bonds have tumbled and yields have popped to two-year highs of about … Read more

Matt Damon crypto trading: How much you would have lost if you invested then

Remember when Matt Damon told you, “Fortune favors the brave”? Well, Twitter TWTR, -9.67% users do, and many of them are bringing up the viral Crypto.com ad, while prices for cryptocurrency like bitcoin BTCUSD, -0.74% and ether ETHUSD, -1.51% are slumping, and crypto exchange platforms like Coinbase COIN, +16.02% are losing billions in market cap. … Read more

Stocks Nearly Entered a Bear Market. What History Says Happens Next.

Text size Everything in the markets seemed on the verge of collapse this week. NYSE It’s the moment of truth for stocks—and investors might not enjoy what comes next. For a moment this past week, the stock market felt like it was already there. On Thursday morning, the S&P500 index, down 19.6% from its closing … Read more

It Might Not Be Time to Buy Stocks Yet. This Technical Analyst Sees the Market Going Even Lower.

text size Michael Nagle/Bloomberg The major US stock market indexes have lost roughly 12% to 25% this year, a painful setback after two years of gains. Time to buy? Not so fast, based on a technical analysis of current market conditions. Andrew Addison, a veteran market technician, proprietor of the Institutional View research service, and … Read more

The FDA Approved Eli Lilly’s Diabetes Drug. But the Most Exciting Market May Be Something Else.

text size While the S&P 500 has dropped 4.4% in the past 12 months, Eli Lilly shares are up 50%. Jonathan Weiss/Dreamstime The US Food and Drug Administration approved Eli Lilly ‘s novel treatment for diabetes on Friday, in a widely anticipated move after the drug led to impressive drops in blood sugar and body … Read more